Who Just RaisedDothan, AL · Health Care · Form D filed Aug 13, 2026
Khaya Biosciences, Inc. raised $200K
Khaya Biosciences, Inc. is a biotechnology company based in Dothan, Alabama. In a Form D filed with the SEC on August 13, 2026, it reported raising $200,000 from 2 investors as part of an offering of up to $850,000. The first sale in the offering took place on February 5, 2026.
- First Form D. This is the first new Form D notice the company has filed with the SEC: likely its first priced outside round.
- Still raising. $650K of the $850K offering was still unsold at filing.
$200K raised since 2020
1 Form D offering, as reported to the SEC. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Aug 13, 2026 | $200K | $850K | 2 |
Lead score
33 out of 100
first raise ever still raising young company
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Amount raised
- $200,000
- Offering size
- $850,000
- Investors so far
- 2
- Minimum investment
- $25,000
- First sale
- February 5, 2026
- Securities offered
- Equity, Securities issuable on exercise or conversion
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Dothan, Alabama
- Incorporated
- New York, 2025
- Entity type
- Corporation
- Revenue range
- No Revenues
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $200,000 | $850,000 | 2 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Aug 10, 2026 · Raises in Alabama · August 2026 funding report
Similar raises
Galvix Recovery Solutions Corp
Fairhope, AL · filed Sep 21First Form DStill raising
SmartCare Northeast Surgery Center, LLC
Birmingham, AL · filed Sep 16First Form DStill raising
Gulf Sterilization, Inc.
Mobile, AL · filed Aug 17
Gulf Sterilization's facility, located in Mobile, Alabama provides safe, efficient, chlorine dioxide sterilization and decontamination services.
2nd Form D since 2025Still raising
Estuary Biotherapeutics, Inc.
Menlo Park, CA · filed Oct 16First Form DStill raising
North Elam Ambulatory Surgery Center, LLC
Greensboro, NC · filed Oct 16First Form DStill raising
Immorta Bio, Inc.
Miami Beach, FL · filed Oct 162nd Form D since 2026Still raising
Lamina Surgical, Inc.
Oakland, CA · filed Oct 16
Making Open Surgery Safer | Lamina
First Form DStill raising
J3 Bioscience, Inc.
Salt Lake City, UT · filed Oct 1612th Form D since 2012